Cargando…
Exploring Metabolic Signatures of Ex Vivo Tumor Tissue Cultures for Prediction of Chemosensitivity in Ovarian Cancer
SIMPLE SUMMARY: Women diagnosed with ovarian cancer have 5-year survival rates below 45%. Prediction of patient’s outcome and the onset of drug resistance are still major challenges. The patient’s drug response is influenced by the environment that surrounds the tumor cells. We previously showed tha...
Autores principales: | Mendes, Rita, Graça, Gonçalo, Silva, Fernanda, Guerreiro, Ana C. L., Gomes-Alves, Patrícia, Serpa, Jacinta, Boghaert, Erwin R., Alves, Paula M., Félix, Ana, Brito, Catarina, Isidro, Inês A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496731/ https://www.ncbi.nlm.nih.gov/pubmed/36139619 http://dx.doi.org/10.3390/cancers14184460 |
Ejemplares similares
-
Application of LDH assay for therapeutic efficacy evaluation of ex vivo tumor models
por: Cox, Megan C., et al.
Publicado: (2021) -
Patient-derived ovarian cancer explants: preserved viability and histopathological features in long-term agitation-based cultures
por: Abreu, Sofia, et al.
Publicado: (2020) -
Unveiling dynamic metabolic signatures in human induced pluripotent and neural stem cells
por: Vasconcelos e Sá, João, et al.
Publicado: (2020) -
Cysteine Boosts Fitness Under Hypoxia-Mimicked Conditions in Ovarian Cancer by Metabolic Reprogramming
por: Nunes, Sofia C., et al.
Publicado: (2021) -
Cell death induced by HDACS inhibitors in ovarian cancer cell lines (serous and clear cells carcinomas) – role of NOTCH, TP53 and FN1
por: Silva, Fernanda, et al.
Publicado: (2010)